Johnson & Johnson Discontinues Phase 2 Study of Investigational Dengue Virus Drug-March 2024-www.financetom.com

Johnson & Johnson Discontinues Phase 2 Study of Investigational Dengue Virus Drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Johnson & Johnson Discontinues Phase 2 Study of Investigational Dengue Virus Drug

Oct 4, 2024 8:20 AM

10:19 AM EDT, 10/04/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday it is discontinuing a phase 2 field study assessing the efficacy of its investigational antiviral drug mosnodenvir for the prevention of dengue virus.

The discontinuation is part of a reprioritization of company's communicable diseases research and development portfolio, J&J said, adding that no safety issues were found.

Johnson & Johnson ( JNJ ) shares were down 0.6% in recent trading.

Price: 159.63, Change: -0.88, Percent Change: -0.55

Previous page： Chart Industries Q2 Adjusted Earnings Rise, Sales Decline Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Chart Industries Q2 Adjusted Earnings Rise, Sales Decline

Jul 29, 2025

06:54 AM EDT, 07/29/2025 (MT Newswires) -- Chart Industries ( GTLS ) reported Q2 adjusted earnings Tuesday of $2.59 per diluted share, up from $2.18 a year earlier. Analysts polled by FactSet expected $2.48. Sales for the quarter ended June 30 were $1.08 billion, compared with $1.04 billion a year earlier. Analysts polled by FactSet expected $1.11 billion. The company...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Vizsla Silver Provides Exploration Updates on Panuco Silver-Gold District Projects

Jul 29, 2025

06:53 AM EDT, 07/29/2025 (MT Newswires) -- Vizsla Silver ( VZLA ) on Tuesday said it completed a horizontal-loop electromagnetic survey covering the Copala and Napoleon Vein corridors at the Panuco silver-gold district in Mexico. The Copala structure remains open down-dip in the south and along strike to the north. Napoleon HW4 is a shallow dipping vein that splays off...

Royal Caribbean Q2 Adjusted Earnings Increase; Full-Year EPS Adjusted Guidance Revised

Jul 29, 2025

06:54 AM EDT, 07/29/2025 (MT Newswires) -- Royal Caribbean (RCL) reported Q2 adjusted earnings Tuesday of $4.38 per share, up from $3.21 per share a year earlier. Analysts polled by FactSet expected $4.09 per share. Total revenue for the quarter ended June 30 was $4.54 billion, compared with $4.11 billion a year ago. Analysts surveyed by FactSet expected $4.55 billion....